Castle Biosciences, Inc. · NASDAQ:CSTL
Castle Biosciences, Inc. shareholders
As of Sep 30, 2026, 195 institutions reported holding Castle Biosciences, Inc., 92.0% of its shares. Largest: BlackRock, Rtw Investments, LP and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Castle Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 3.45M | 11.2% | +162K | Nov 13, 2026 |
| Rtw Investments, LP | 2.78M | 9.0% | no change | Nov 16, 2026 |
| Vanguard | 2.2M | 7.1% | −105K | Nov 13, 2026 |
| Principal | 1.5M | 4.9% | −226K | Nov 2, 2026 |
| Portolan Capital Management, LLC | 1.37M | 4.5% | +1.04M | Nov 16, 2026 |
| Acadian Asset Management LLC | 882K | 2.9% | −36,805 | Nov 9, 2026 |
| State Street | 805K | 2.6% | −17,397 | Nov 12, 2026 |
| Geode Capital | 794K | 2.6% | −2,008 | Nov 6, 2026 |
| Dimensional | 692K | 2.2% | −98,981 | Nov 4, 2026 |
| Jefferies Financial Group Inc. | 647K | 2.1% | no change | Nov 5, 2026 |